Pharmaceutical

Semaglutide (Ozempic / Wegovy / Rybelsus)

Ozempic, Wegovy, Rybelsus, and Mounjaro have been linked to severe gastroparesis, ileus, and vision loss (NAION).

Overview

GLP-1 receptor agonists prescribed for diabetes and weight loss have been associated with severe and sometimes permanent gastrointestinal injury — including stomach paralysis (gastroparesis) and intestinal blockage — as well as a serious eye condition (NAION) that can cause sudden vision loss.

Who is affected

  • Patients prescribed Ozempic, Wegovy, Rybelsus, or Mounjaro

Conditions and diseases

  • Gastroparesis (stomach paralysis)
  • Ileus / intestinal obstruction
  • Cyclic vomiting syndrome
  • NAION (non-arteritic anterior ischemic optic neuropathy)
Free, Confidential Case Evaluation

Tell us what happened. We’ll tell you whether you have a case.

No fee unless we recover for you. All consultations are confidential and protected by attorney–client privilege.